Blog
RSS FeedPosted by Michael Wonder on 08 Mar 2022
Scottish Medicines Consortium update
7 March 2022 - Diurnal provides an update on the status of reimbursement of Efmody (modified release hydrocortisone) for NHS ...
Posted by Michael Wonder on 07 Mar 2022
SMC - March 2022 decisions
7 March 2022 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...
Posted by Michael Wonder on 10 Feb 2022
SMC approves Biogen’s Vumerity for patients with multiple sclerosis
9 February 2022 - The new, at home oral treatment has been developed for adults in Scotland living with relapsing-remitting multiple ...
Posted by Michael Wonder on 09 Feb 2022
Angelini Pharma’s Ontozry available for patients in Scotland with drug resistant epilepsy
9 February 2022 - SMC accepts promising new therapy which offers a better quality of life to patients with epilepsy ...
Posted by Michael Wonder on 08 Feb 2022
Cannabis-based medicine among batch of new drugs approved for use in Scotland
8 February 2022 - The medicines have been approved for use by the Scottish Medicines Consortium. ...
Posted by Michael Wonder on 07 Feb 2022
SMC - February 2022 decisions
7 February 2022 - Advice on six new medicines for use in conditions including a rare lung cancer caused by ...
Posted by Michael Wonder on 24 Jan 2022
Breast cancer patients in Scotland are set to receive tumour blasting wonder drug that starts working in weeks - sparking hopes of a wider rollout for NHS patients across the rest of the UK
23 January 2022 - A breast cancer drug that can melt away tumours in weeks has been given the green ...
Posted by Michael Wonder on 17 Jan 2022
SMC - January 2022 decisions
17 January 2022 - Advice on four new medicines for use in conditions including advanced breast cancer and non-small cell ...
Posted by Michael Wonder on 14 Dec 2021
SMC approves first immunotherapy combination for advanced bowel cancer patients with rare mutation
14 December 2021 - Nivolumab plus ipilmumab has been accepted as a treatment option for adult patients by NHS Scotland ...
Posted by Michael Wonder on 13 Dec 2021
SMC - December 2021 decisions
13 December 2021 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has published ...
Posted by Michael Wonder on 11 Nov 2021
Three cancer drugs approved for NHS use in Scotland
10 November 2021 - Three new cancer drugs have been given the go-ahead by the SMC for routine use in ...
Posted by Michael Wonder on 10 Nov 2021
SMC accepts oral therapy for relapsing multiple sclerosis
10 November 2021 - Janssen has announced that the SMC have accepted Ponvory (ponesimod) within NHS Scotland, as a treatment for ...
Posted by Michael Wonder on 08 Nov 2021
SMC - November 2021 decisions
8 November 2021 - The Scottish Medicines Consortium which advises on newly licensed medicines for use by NHSScotland has published ...
Posted by Michael Wonder on 13 Oct 2021
SMC accepts Cabometyx/Opdivo combo for advanced kidney cancer patients
13 October 2021 - The SMC has recommended Cabometyx (cabozantinib) plus Opdivo (nivolumab) for use by via NHS Scotland for ...
Posted by Michael Wonder on 13 Oct 2021
Scotland is first country to offer free digital therapies to every adult
13 October 2021 - The Scottish Government has announced that all Scottish adults will now have access to "digital therapeutics" ...